Covid-19: Bharat Biotech's nasal vaccine cleared for use

NEW DELHI: The Drugs Controller General of India (DCGI) approved Bharat Biotech's Covid-19 recombinant nasal vaccine, health minister Mansukh Mandaviya tweeted on Tuesday. Notably, this will be India's first nasal vaccine for coronavirus.

► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1

► More Videos @ ETTV - http://economictimes.indiatimes.com/TV

► http://EconomicTimes.com

► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp

Follow ET on:

► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes

The Economic Times | A Times Internet Limited product

Тэги:

#Business_News #Financial_News #DCGI #nasal_vaccine #Bharat_Biotech's_nasal_vaccine

Скачать видео